Hepatic and Intestinal First-Pass Effects of Rabeprazole in Rabbits

查德华,张磊,许建明,梅俏,胡咏梅,徐新华,金娟

DOI: https://doi.org/10.3321/j.issn:1001-1978.2008.10.029

2008-01-01

Abstract:Aim To investigate the pharmacokinetics of rabeprazole after intravenous,intraportal and intraduodenal administration at various doses and to clarify the impact of hepatic and intestinal first-pass effects to bioavailability of rabbits.Methods By developing an in vivo intestinal and vascular access-ported(IVAP) rabbit model,doses of 0.75,1.5,3 mg·kg-1(intravenous);1.5,3 mg·kg-1(intraportal) and 1.5,3,6 mg·kg-1(intraduodenal) were administered to rabbits respectively.Serial blood samples were collected at various time points,and plasma drug concentration was analyzed by a high-performance liquid chromatography fluorescence method.Then the pharmacokinetic parameters were evaluated and absolute bioavailability and hepatic and intestinal extraction ratios were calculated.Results The pharmacokinetic parameters AUC0-t、AUC0-∞ and Cmax increased significantly with increasing doses of intravenous,intraportal and intraduodenal administration respectively (P0.05),and there were no differences in elimination half-life at any dose in intravenous,intraportal and intraduodenal administration respectively(P0.05).But the clearance decreased significantly with increasing doses(P0.05). The absolute bioavailability of rabeprazole after intraduodenal administration was 7.4% and 8.3% at the dose of 1.5 mg·kg-1 and 3 mg·kg-1 respectively;the hepatic extraction ratio was 84.8% and 81.2%,and the intestinal extraction ratio was 51.2% and 56% at the dose of 1.5 and 3 mg·kg-1,respectively.Conclusions AUC0-t、AUC0-∞ and Cmax were dose-dependent at intravenous,intraportal and intraduodenal administration in rabbits.The bioavailability of rabeprazole was low at the intraduodenal administration,and was not dose-dependent. The major reason could be rabeprazole undergoing considerable hepatic and intestinal first-pass effects.